Compounds > xanthenes
Page last updated: 2024-08-18

xanthenes and Carcinoma, Ovarian Epithelial

xanthenes has been researched along with Carcinoma, Ovarian Epithelial in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, H; Sheng, WJ; Wu, DL; Zheng, JH1

Other Studies

1 other study(ies) available for xanthenes and Carcinoma, Ovarian Epithelial

ArticleYear
Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2013, Volume: 46, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; bcl-X Protein; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Migration Assays; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Oxazines; Rats; Signal Transduction; STAT3 Transcription Factor; Survivin; Vascular Endothelial Growth Factor A; Xanthenes

2013